NCT07052825

Brief Summary

Study Purpose: This prospective, self-controlled clinical study aims to evaluate the impact of capsular tension rings (CTR) on intraocular lens (IOL) stability in high myopia patients undergoing bilateral cataract surgery. Each patient will receive CTR implantation in one eye, with the fellow eye serving as control. Postoperative outcomes, including visual acuity, refraction, IOL positioning, and visual quality, will be compared between eyes to assess the effectiveness of CTR. Study Methods: Eligible participants (axial length ≥ 26.0 mm) will undergo femtosecond-assisted phacoemulsification with identical IOLs implanted in both eyes. One eye will be randomly assigned to receive a CTR. All surgeries will be performed by the same surgeon. Follow-up will be conducted at 1 day, 1 week, 1 month, 3 months, and 6 months postoperatively. Assessments will include UCVA, BCVA, refractive error, anterior segment OCT, IOL decentration and tilt, and visual quality (iTrace). Sample Size and Population: A total of 60 patients (120 eyes) will be enrolled. Inclusion criteria include age ≥ 18 years and bilateral cataracts with high myopia. Exclusion criteria include other ocular diseases, history of severe ocular trauma, or poor visual potential. Patients will be stratified by axial length into three groups: ≤28 mm, 28-30 mm, and \>30 mm. Study Procedure: After informed consent and baseline examinations (including ocular biometry and imaging), patients will undergo surgery and be followed at specified intervals. All data will be managed securely. Comparative analysis between CTR and non-CTR eyes will be performed to evaluate the effect of CTR on IOL stability and visual outcomes in highly myopic cataract patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
57mo left

Started Jan 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Jan 2025Dec 2030

Study Start

First participant enrolled

January 1, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 29, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 7, 2025

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

July 7, 2025

Status Verified

June 1, 2025

Enrollment Period

6 years

First QC Date

June 29, 2025

Last Update Submit

June 29, 2025

Conditions

Keywords

Capsular Tension Ring(CTR), High Myopia, Intraocular lens, Tilt, Decentration, Visual Quality

Outcome Measures

Primary Outcomes (1)

  • Tilt and Decentration

    measured by using anterior segment OCT

    Postoperative follow-up visits will be scheduled at 1 day, 1 week, 1 month, 3 months, and 6 months

Secondary Outcomes (3)

  • Anterior Capsular Contraction

    1 day, 1 week, 1 month, 3 months, and 6 months postoperatively

  • visual acuity

    1 day, 1 week, 1 month, 3 months, and 6 months postoperatively

  • Visual Quality

    1 day, 1 week, 1 month, 3 months, and 6 months postoperatively

Study Arms (2)

CTR implantation

EXPERIMENTAL

Phaco+IOL with CTR implantation

Procedure: CTR implantation

NCTR

NO INTERVENTION

Phaco+IOL without CTR implantation

Interventions

Phaco+IOL with CTR implantation

CTR implantation

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years.
  • Diagnosed with bilateral age-related cataracts and scheduled for phacoemulsification with IOL implantation in both eyes.
  • High myopia in both eyes, defined as axial length (AL) ≥ 26.0 mm.
  • No significant difference in axial length between the two eyes (e.g., interocular AL difference \< 1.0 mm).
  • Willingness and ability to undergo bilateral surgery within a short interval (e.g., within 1-2 weeks).
  • Able to provide informed consent and comply with the study protocol and follow-up visits.

You may not qualify if:

  • History of ocular trauma, surgery, or intraocular inflammation in either eye.
  • Presence of other ocular diseases that may affect visual outcomes, such as glaucoma, diabetic retinopathy, macular degeneration, or corneal opacity.
  • Evidence of zonular weakness, pseudoexfoliation, or significant phacodonesis preoperatively.
  • Severe dry eye or poor fixation that may interfere with postoperative imaging.
  • Systemic diseases affecting visual function (e.g., uncontrolled diabetes, neurologic disorders).
  • Participation in other clinical trials that may affect the study outcomes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eye and ENT hospital of Fudan University

Shanghai, Shanghai Municipality, 200000, China

RECRUITING

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Jin Yang

    Fudan University

    STUDY CHAIR

Central Study Contacts

Baoxian Zhuo

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This is a self-controlled study. Each participant receives cataract surgery in both eyes, with one eye randomly assigned to CTR implantation and the fellow eye without CTR. The two eyes serve as within-subject comparators.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chief Physician

Study Record Dates

First Submitted

June 29, 2025

First Posted

July 7, 2025

Study Start

January 1, 2025

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Last Updated

July 7, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations